These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33151566)

  • 1. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
    Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
    J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma.
    Mascitti M; Togni L; Caponio VCA; Zhurakivska K; Lo Muzio L; Rubini C; Santarelli A; Troiano G
    Oral Dis; 2023 Jul; 29(5):1947-1958. PubMed ID: 35316866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer.
    Almangush A; Bello IO; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Nieminen O; Soini Y; Kosma VM; Koivunen P; Grénman R; Leivo I; Salo T
    Head Neck; 2014 Jun; 36(6):811-8. PubMed ID: 23696499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies.
    Almangush A; Leivo I; Siponen M; Sundquist E; Mroueh R; Mäkitie AA; Soini Y; Haglund C; Nieminen P; Salo T
    Virchows Arch; 2018 Feb; 472(2):231-236. PubMed ID: 28766010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding.
    Elseragy A; Salo T; Coletta RD; Kowalski LP; Haglund C; Nieminen P; Mäkitie AA; Leivo I; Almangush A
    Am J Surg Pathol; 2019 May; 43(5):703-709. PubMed ID: 30829728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of TFIIH and XPF in oral tongue squamous cell carcinoma.
    Sá MC; Conceição TS; de Moura Santos E; de Morais EF; Galvão HC; de Almeida Freitas R
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):893-902. PubMed ID: 31828418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: a comparative study.
    Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Patel SG; Katabi N; Ghossein R
    Virchows Arch; 2021 Sep; 479(3):597-606. PubMed ID: 33661329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
    Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
    J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma.
    Caponio VCA; Troiano G; Togni L; Zhurakivska K; Santarelli A; Laino L; Rubini C; Lo Muzio L; Mascitti M
    Oral Dis; 2023 Mar; 29(2):411-422. PubMed ID: 33964054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality.
    Almangush A; Bello IO; Coletta RD; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kosma VM; Koivunen P; Kelner N; Kowalski LP; Grénman R; Leivo I; Läärä E; Salo T
    Virchows Arch; 2015 Jul; 467(1):39-46. PubMed ID: 25838076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
    Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
    Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
    Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
    Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
    Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
    Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
    Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T
    Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
    Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
    J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
    Almangush A; Hagström J; Haglund C; Kowalski LP; Coletta RD; Mäkitie AA; Salo T; Leivo I
    BMC Cancer; 2024 Feb; 24(1):213. PubMed ID: 38360653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple novel prognostic model for early stage oral tongue cancer.
    Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
    Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
    Liu L; Wang X; Ge W
    Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
    Almangush A; Bello IO; Elseragy A; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
    BMC Cancer; 2022 Oct; 22(1):1108. PubMed ID: 36309667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
    Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
    J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.